Skip to main content
. 2023 Jan 12;41(9):1296–1306. doi: 10.1038/s41587-022-01626-2

Extended Data Table 3.

Individual anti-drug antibody (ADA) ratio of cynomolgus monkeys treated with CD123-NKCE

graphic file with name 41587_2022_1626_Tab3_ESM.jpg

Individual anti-drug antibody (ADA) ratio (fold-change from baseline value collected at Day 1 Predose) after a weekly repeat 1-hour intravenous infusion of CD123-NKCE at 0.1 and 3 mg/kg/administration for 4 weeks (on Days 1, 8, 15 and 22) to cynomolgus monkeys are shown. Under the assay conditions, the presence of ADA is considered to be significant when the ADA ratio is above 3.0 or, for ratio below 3.0, when the ratio increase with time.